Geode Capital Management
SLNO icon

Geode Capital Management’s Soleno Therapeutics SLNO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$75.6M Buy
902,396
+286,660
+47% +$24M 0.01% 1193
2025
Q1
$44M Buy
615,736
+16,617
+3% +$1.19M ﹤0.01% 1444
2024
Q4
$26.9M Buy
599,119
+58,823
+11% +$2.64M ﹤0.01% 1797
2024
Q3
$27.3M Buy
540,296
+51,189
+10% +$2.59M ﹤0.01% 1815
2024
Q2
$20M Buy
489,107
+322,086
+193% +$13.1M ﹤0.01% 1929
2024
Q1
$7.15M Buy
167,021
+4,177
+3% +$179K ﹤0.01% 2521
2023
Q4
$6.56M Buy
162,844
+110,291
+210% +$4.44M ﹤0.01% 2565
2023
Q3
$1.55M Sell
52,553
-2,095
-4% -$61.8K ﹤0.01% 3164
2023
Q2
$234K Buy
54,648
+22,092
+68% +$94.8K ﹤0.01% 3976
2023
Q1
$69.7K Hold
32,556
﹤0.01% 4442
2022
Q4
$64K Hold
32,556
﹤0.01% 4526
2022
Q3
$54K Sell
32,556
-455,837
-93% -$756K ﹤0.01% 4752
2022
Q2
$90K Buy
488,393
+58,140
+14% +$10.7K ﹤0.01% 4631
2022
Q1
$95K Hold
430,253
﹤0.01% 4679
2021
Q4
$176K Hold
430,253
﹤0.01% 4535
2021
Q3
$397K Buy
430,253
+18,185
+4% +$16.8K ﹤0.01% 4143
2021
Q2
$469K Sell
412,068
-415,678
-50% -$473K ﹤0.01% 3974
2021
Q1
$1.04M Buy
827,746
+108,234
+15% +$136K ﹤0.01% 3542
2020
Q4
$1.39M Buy
719,512
+152,504
+27% +$294K ﹤0.01% 3256
2020
Q3
$1.42M Buy
567,008
+199,132
+54% +$500K ﹤0.01% 3065
2020
Q2
$816K Buy
367,876
+227,711
+162% +$505K ﹤0.01% 3206
2020
Q1
$333K Buy
140,165
+83,266
+146% +$198K ﹤0.01% 3390
2019
Q4
$167K Buy
56,899
+21,802
+62% +$64K ﹤0.01% 3859
2019
Q3
$52K Hold
35,097
﹤0.01% 4058
2019
Q2
$98K Buy
35,097
+6,062
+21% +$16.9K ﹤0.01% 3967
2019
Q1
$59K Hold
29,035
﹤0.01% 3988
2018
Q4
$49K Hold
29,035
﹤0.01% 3992
2018
Q3
$62K Buy
+29,035
New +$62K ﹤0.01% 4004